News

08/06/2011

Oryzon is present in the 76th Spanish National Congress of Urology

17/05/2011

Oryzon presents the results of the clinical study of GynEC-Dx: detection of endometrial cancer product

01/04/2011

Oryzon to Present at BioTrinity 2011 Conference in UK

01/03/2011

Oryzon to Present Recent Advances from its Project 'Innovative Approaches and Biomarkers in Parkinson Disease' at a Symposium in Barcelona

12/11/2010

Oryzon Licenses Human Antibody Phage Display Technology for Discovery of Novel Therapeutics

Oryzon announced today that it has signed a non-exclusive license with Dyax Corp. (NASDAQ:DYAX), a developer of novel biotherapeutics for unmet medical needs, to develop therapeutic antibody products using Dyax’s proprietary technology, phage display.

13/09/2010

Oryzon to Participate at the SMR Epigenetics symposium in London, UK.